发明名称 HBV polymerase mutants
摘要 The present invention relates to polymerase HBV mutant polypeptides comprising a mutated polymerase domain which is functionally disrupted for polymerase activity and fusion proteins comprising such polymerase mutant polypeptide. The present invention also relates to a nucleic acid molecule and an expression vector for expressing said polymerase mutant polypeptide as well as a composition which can be used for eliciting an immune response to HBV with the goal of providing a protective or therapeutic effect against HBV infection.
申请公布号 US9512412(B2) 申请公布日期 2016.12.06
申请号 US201214232082 申请日期 2012.07.12
申请人 Transgene S.A. 发明人 Martin Perrine;Silvestre Nathalie;Marchand Jean-Baptiste
分类号 C12N9/12;C12N9/22;A61K38/00;A61K39/00 主分类号 C12N9/12
代理机构 Buchanan Ingersoll & Rooney PC 代理人 Buchanan Ingersoll & Rooney PC
主权项 1. A nucleic acid molecule coding for a mutant polypeptide which comprises a mutated HBV polymerase domain with an internal deletion that functionally disrupts the polymerase activity, wherein said internal deletion is of at least 4 amino acid residues and at most 30 amino acid residues, said mutated polymerase domain comprising: the amino acid sequence shown in SEQ ID NO:1 but lacking at least the Tyr residue in position 203, the Met residue in position 204, the Asp residue in position 205, the Asp residue in position 206, the Val residue in position 207, the Val residue in position 208, and the Leu residue in position 209.
地址 Illkirch Greffenstaden FR